List of findings

Use the filters on the left to narrow down the list of findings, or use "Browse by keyword" on the right to locate a specific finding.

Global methamphetamine seizures reached another record high in 2024, with the highest growth rates reported by so-called emerging markets.East and South-East Asia and North America continue to account for the largest methamphetamine seizures globally, although seizures declined in North America…
There continue to be challenges in the interdiction and reporting of laboratories and precursors as traffickers continue to shift precursors and production locations to avoid interceptionsfor the manufacture of methamphetamine in Europe seems to be largely limited to the Kingdom of the Netherlands…
Most methamphetamine trafficking remains intra-regional, although some inter-regional trafficking has also been detected in recent years.The largest markets for methamphetamine – and most intra-regional trafficking – remain in East and South-East Asia and North America, although trafficking has…
Overall, of the four major modes of transport used for drug trafficking – by land, water, air and mail (including courier services) – land or maritime routes (depending on the specific drug) dominate in terms of volume.Around 2024, there appeared to be an increased preference for smaller shipments…
Seven substances dominate the global availability of opioids under international control for medical consumption.Expressed in S-DDDs (defined daily doses for statistical purposes), methadone, followed by hydrocodone, fentanyl, buprenorphine, oxycodone, codeine (including preparations) and morphine…
The type of opioid that is most used non-medically varies across regions and countries.With the highest population globally, Asia is also the region with the highest number of people who use opioids.The type of opioid used differs across regions, with opiates such as heroin dominating in Asia and…
Similarly to most internationally controlled drugs, the use of NPS among adolescents is higher than among the general population, but the difference between adolescent boys and girlsis lower for NPS than for controlled drugs.Limited data suggest that NPS use is generally higher among school…
Opioid-related harms, measured as new people entering treatment, have declined in Europe.Although the share of people in treatment for opioid use disorders remains substantial in Europe, the number of people entering treatment for the first time has decreased.In Eastern Europe and South-Eastern…
The use of buprenorphine and methadone for medical purposes continues to expandMethadone and buprenorphine are the main substances used in substitution treatment for opioid dependent persons worldwide. Availability of both substances for medical use rose 10-fold over the last two decades and…
Opium production and opiate seizures are closely linked, but stockpiling has partly mitigated recent supply shocks.Opiate seizures have generally moved in parallel with opium production over time, but production has been far more volatile. Following the transfer of power in Afghanistan in 2021 and…
Amphetamine seizures rose strongly until 2020-2021, declined thereafter and showed a modest rebound in 2024.Amphetamine seizures remain concentrated in the Near and Middle East (57 per cent of total seizures between 2020 and 2024) and Europe (26 per cent); in the former subregion much of the drug…
The number of NPS on the global market increased strongly in 2024 following a short period of decline between 2021 and 2023.The number of NPS on the global market rose by 30 per cent in 2024 compared to 2023 and reached a new record high of 755 substances – the number rose almost five-fold compared…